[Clinical study on a new synthetic antihistaminic: trans-1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-one chlorhydrate].
D018926:Anti-Allergic Agents; D035843:Biomedical Research; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists
ANTIHISTAMINICS/therapeutic use
Etude clinique d'un nouvel antihistaminique de synthèse: le chlorhydrate de trans-1-(4-méthylphényl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ène.